Arkolith/Insider Trading/MLYS/Form 4

Slingsby Brian Taylor

Director, 10% OwnerMineralys Therapeutics, Inc. (MLYS) · full profile →Form 4 · filed Feb 20, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 19, 2026Other(J)6K—$00
Feb 19, 2026Other(J)6K—$07.9M
Feb 19, 2026Grant(A)6K—$06K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 19, 2026Grant(A)8K—$08K
Feb 19, 2026Other(J)8K—$00
Feb 19, 2026Other(J)8K—$08K

Transaction Codes

J
Other acquisition / disposition
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001933414-26-000041) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML